Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and markets therapeutic and pharmaceutical products in China, the United States, and internationally. The company is headquartered in Rockville, Maryland.
52W High
$7.67
52W Low
$1.09
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.72
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.07
EV/Revenue (<3 favorable)
1.53
P/S (TTM) (<3 favorable)
1.15
P/B (<3 favorable)
11.21
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
48.39%
Institutions (25–75% balanced)
20.42%
Shares Outstanding
15,492,800
Float
5,977,100
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
31,564,000
Gross Profit (TTM)
12,950,000
EPS (TTM)
-2.89
Profit Margin (>10% good)
-1.49%
Operating Margin (TTM) (higher better)
-2.57%
ROE (TTM) (>15% strong)
-10.95%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.05
Momentum
Bearish momentumValue
0.1438
Previous
0.1602
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025